Back to News
Market Impact: 0.35

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LIVN
Corporate EarningsAnalyst EstimatesCompany FundamentalsHealthcare & Biotech

LivaNova reported quarterly EPS of $0.98, ahead of the Zacks Consensus Estimate of $0.85 and up from $0.88 a year ago. The result indicates a modest earnings beat and slightly improved profitability year over year. This is positive for the stock, but the article provides no revenue or guidance details to suggest a larger re-rating.

Analysis

LivaNova reported quarterly EPS of $0.98, ahead of the Zacks Consensus Estimate of $0.85 and up from $0.88 a year ago. The result indicates a modest earnings beat and slightly improved profitability year over year. This is positive for the stock, but the article provides no revenue or guidance details to suggest a larger re-rating.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

LIVN0.45